Clinical Trials Logo

Sleep Apnea, Obstructive clinical trials

View clinical trials related to Sleep Apnea, Obstructive.

Filter by:

NCT ID: NCT03432910 Recruiting - Clinical trials for Sleep Apnea, Obstructive

Application of Forced Breath Technique While CPAP Therapy for Apnea Classification

FBT-CPAP
Start date: March 24, 2016
Phase: N/A
Study type: Interventional

This study analyzes the application of the Forced Breath Technique (FBT) to classify apneas during CPAP therapy with a prismaLAB (device name) therapy device. In this study the BiLevel ST (Spontaneous / Timed) therapy mode of the prismaLAB device is reduced to a CPAP pressure profile with exhalation relief by minimization of the pressure gap between exhalation and inhalation pressure. The FBT based apnea classification of the devices firmware is matched with the by hand scoring of the polysomnographic data that is usually used to evaluate the quality of patients sleep.

NCT ID: NCT03431038 Active, not recruiting - Clinical trials for Sleep Apnea, Obstructive

Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH

Start date: September 1, 2017
Phase: N/A
Study type: Observational

This study explore AAA prevalence in OSAHS patients by ultrasound screening and try to analysis risk factors of AAA in OSAHS patients.

NCT ID: NCT03426631 Completed - Clinical trials for Obstructive Sleep Apnea (OSA)

DAW1033B2 in Obstructive Sleep Apnea

OsaStimB2
Start date: September 15, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

Obstructive sleep apnea (OSA) is common and has major health implications but treatment options are limited. OSA patients show a marked reduction in upper airway (UA) dilator muscle activity at sleep onset and this phenomenon leads to increased collapsibility of UA compared to normal subjects. In this protocol the investigators will test the effect of DAW1033B2 administered before sleep on OSA phenotype traits and OSA severity during sleep.

NCT ID: NCT03415633 Completed - Clinical trials for Obstructive Sleep Apnea (OSA)

Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea

APNiA
Start date: September 2015
Phase: N/A
Study type: Interventional

To assess the diagnostic validity and cost-effectiveness of a APNiA device, a home respiratory polygraphy (HRP).

NCT ID: NCT03413098 Completed - Clinical trials for Obstructive Sleep Apnea

The Evaluation of a Novel Nasal Mask for the Treatment of Obstructive Sleep Apnea

Start date: February 12, 2018
Phase: N/A
Study type: Interventional

This investigation is a prospective, non randomized, non blinded study. This investigation is designed to evaluate the performance, comfort and ease of use with the F&P trial nasal mask amongst Obstructive Sleep Apnea (OSA) patients.

NCT ID: NCT03408613 Suspended - Sleep Apnea Clinical Trials

Obstructive Sleep Apnea and Glucose Metabolism

OSAGM
Start date: January 17, 2018
Phase: N/A
Study type: Interventional

Many adults who are overweight have obstructive sleep apnea (OSA) which disrupts sleep and makes it difficult to breath during the night. OSA increases the risk for a person to become insulin resistant and diabetic. It is not known why OSA causes this problem, i.e., whether it is disrupted sleep or lack of oxygen., which can change how the body handles glucose in adipose tissue, muscle tissue and liver. The purpose of this research study is to determine the key issues and mechanisms responsible for dysregulated glucose metabolism in people with OSA. The investigators will do this by comparing glucose metabolism in people who have OSA, and those who do not, and by evaluating the effect of treating OSA by providing continuous positive airway pressure (CPAP) or simply oxygen during the night. The proposed study will evaluate the primary causes(s) (hypoxia, sleep fragmentation, or both) and pathophysiological mechanisms responsible for the OSA-associated metabolic abnormalities. Knowing the primary cause of Obstructive Sleep Apnea and pathophysiological mechanisms responsible for the OSA-associated metabolic abnormalities could help develop potentially novel therapeutic strategies to provide treatment for adults in improving OSA and associated comorbidities.

NCT ID: NCT03400319 Completed - Clinical trials for Obstructive Sleep Apnea

Obstructive Sleep Apnoea in Adolescents With Thoracic Aortic Aneurysm

OSA in TAA
Start date: July 5, 2014
Phase:
Study type: Observational

The objective of this prospective cohort study is to determine the prevalence of obstructive sleep apnoea (OSA) in patients with and without thoracic aortic aneurysm.

NCT ID: NCT03398733 Completed - Clinical trials for Obstructive Sleep Apnea

CPAP Treatment and Postoperative Outcomes in Patients With Rheumatic Valvular Heart Disease

CPAP
Start date: December 1, 2017
Phase: N/A
Study type: Interventional

The prevalence of OSA (Obstructive sleep apnea,OSA) is 2%-4% in general population and 16%-47% in surgical-heart failure patients. Our previous study found that OSA was associated with the increasing incidence of perioperative adverse events.The continuous positive airway pressure (CPAP), as the standard treatment for OSA, is extensively applied clinically. The previous study reported that postoperative AHI was reduced and SPO2 was increased by CPAP treatment. However, whether CPAP treatment can improve OSA postoperative and related adverse events or not in patients with rheumatic valvular heart diseases (RVHD) were not reported.The purpose of this study is to observe the effective of preoperative CPAP on postoperative sleep parameters and adverse events, such as AHI changes, duration of ICU stay and duration of mechanical ventilation.

NCT ID: NCT03398044 Completed - Hearing Loss Clinical Trials

Administration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Adenotomy, together with tonsillectomy, belongs among the most frequently performed surgical procedures in paediatric patients. These surgical procedures are associated with the second highest incidence of post-operative nausea and vomiting (PONV) (following strabism correction surgery) in paediatric surgery. PONV is associated, apart from the discomfort for the child, with a number of complications: dehydration, metabolic disruption or danger of haemorrhage and aspiration of the gastric content. Adenotomy is a typologically completely different surgical procedure, with a different target structure of the surgery, and the length and invasiveness of the procedure. Thus, it is possible to expect a difference in PONV incidence when compared to tonsillectomy. Adenotomy is a surgical procedure performed namely in children of the pre-school age. This is associated, among others, also with the problem of objectivization of post-operative nausea, which is very difficult to verbalize in small children, being a subjective feeling of body discomfort. It is possible to expect that the overall incidence of PONV will be significantly underestimated.

NCT ID: NCT03391141 Completed - Clinical trials for Obstructive Sleep Apnea

Diagnostic Validation of Drug-Induced Sleep Endoscopy (DISE)

Start date: April 9, 2018
Phase:
Study type: Observational

This study aims to validate whether the pattern of airway collapse recorded during Drug-Induced Sleep Endoscopy (DISE) mirrors that of natural sleep, and to develop a model for airway collapse. Sensors will be placed in subjects' upper airways during DISE and then during in-lab sleep studies. The sleep study results will be compared with OR findings to create an aerodynamic model for natural sleep and to assess whether airway observations during DISE were valid representations of natural sleep.